Suppression of malignancy utilizing ribonucleotide reductase R1

    公开(公告)号:US20030087866A1

    公开(公告)日:2003-05-08

    申请号:US10223655

    申请日:2002-08-20

    IPC分类号: A61K048/00 C12N015/85

    摘要: The present invention provides a method of modulating the malignant properties of a cell in a human or other mammal by contacting a neoplastic cell with a growth modulating amount of an expressible nucleic acid sequence for ribonucleotide reductase R1 of the mammal. The present invention also provides and uses a growth modulating amount of the ribonucleotide reductase R1 protein or biologically active peptide to modulate the malignant properties of a cell in a human or other mammal. The method provides for a generally elevated expression of the R1 component of mammalian ribonucleotide reductase. The expressible nucleic acid sequence can be in the form of a vector for gene therapy.

    Insulin-like growth factor II antisense oligonucleotide sequences and methods of using same to modulate cell growth
    3.
    发明申请
    Insulin-like growth factor II antisense oligonucleotide sequences and methods of using same to modulate cell growth 审中-公开
    胰岛素样生长因子II反义寡核苷酸序列及其使用方法来调节细胞生长

    公开(公告)号:US20020187954A1

    公开(公告)日:2002-12-12

    申请号:US10125181

    申请日:2002-04-17

    IPC分类号: A61K048/00

    摘要: This invention relates to oligonucleotides complementary to the IGF-II genes which modulate tumor cell growth in mammals This invention is also related to methods of using such compounds in inhibiting the growth of tumor cells in mammals This invention also relates to pharmaceutical compositions comprising a pharmaceutically acceptable excipient and an effective amount of a compound of this invention.

    摘要翻译: 本发明涉及与调节哺乳动物肿瘤细胞生长的IGF-II基因互补的寡核苷酸本发明还涉及使用这些化合物抑制哺乳动物肿瘤细胞生长的方法。本发明还涉及包含药学上可接受的药物组合物 赋形剂和有效量的本发明化合物。